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T
he drug abuse treatment and criminal justice systems in this country deal
with many of the same individuals. Approximately two-thirds of clients in
long-term residential drug abuse treatment, one-half of clients in outpatient drug
abuse treatment, and one-quarter of clients in methadone maintenance treatment
are currently awaiting a criminal trial or sentencing, have been sentenced to com-
munity supervision on probation, or were conditionally released from prison on
parole (Craddock et al., 1997). Conversely, 60 to 80 percent of prison and jail
inmates, parolees, probationers, and arrestees were under the influence of drugs
or alcohol during the commission of their offense, committed the offense to sup-
port a drug addiction, were charged with a drug- or alcohol-related crime, or are
regular substance users (Belenko and Peugh, 1998).
The co-occurrence of drug abuse and crime is not simply an artifact of crim-
inalizing drug possession. Drug use significantly increases the likelihood that an
individual will engage in serious criminal conduct. More than 50 percent of vio-
lent crimes, including domestic violence, 60 to 80 percent of child abuse and 
neglect cases, 50 to 70 percent of theft and property crimes, and 75 percent of
drug dealing or manufacturing offenses involve drug use on the part of the per-
petrator—and sometimes the victim as well (e.g., Belenko and Peugh, 1998;
National Institute of Justice, 1999). Sustained abstinence from narcotics is asso-
ciated with a 40- to 75-percent reduction in crime (e.g., Harrell and Roman, 2001).
Proponents of a pure public safety perspective on the drug problem hold that drug-involved
offenders require consistent and intensive supervision by criminal justice authorities in order
to stay off drugs and out of trouble. In contrast, proponents of a thoroughgoing public health
perspective commonly argue that clients perform better if they are left alone to develop an
effective therapeutic alliance with counselors. Both may be correct, but with respect to differ-
ent groups of offenders. One approach has shown consistent promise for reducing drug use
and criminal recidivism: an integrated public health-public safety strategy that combines
community-based drug abuse treatment with ongoing criminal justice supervision. This arti-
cle presents promising findings from programs implementing this strategy and discusses
best treatment practices to meet the needs of both low-risk and high-risk clients.RESEARCH REVIEWS—CRIMINAL JUSTICE • 5
More importantly, it increases the likelihood that an
inmate will enter drug abuse treatment after release
from prison (Martin et al., 1999). Possibly, in-prison
services enhance inmates’ motivation for change or
prepare them to use drug abuse treatment services
once they are in the community or in a transitional-
release setting.
Intermediate-sanction programs attempt to reduce
drug use and criminal activity, as well as reduce costs,
by reducing the emphasis on incarceration and insti-
tuting close surveillance of drug-abusing offenders in
the community. In these programs, specially trained
probation or parole officers with light caseloads typ-
ically monitor offenders’ compliance with treatment,
make surprise home visits, demand spot-check urine
samples, phone-monitor compliance with home cur-
fews or house arrest, or interview employers, friends,
and relatives about offenders’ behavior.
Unfortunately, community-based intermediate-
sanction programs have had little impact. Approximately
50 to 70 percent of probationers and parolees fail to
comply with their release conditions, including drug
testing, attendance at drug treatment, and avoidance
of criminal activity (e.g., Taxman, 1999a). Moreover,
no incremental benefits are obtained from intensive
supervised probation and parole programs, electronic
monitoring, boot camps, or house arrest (e.g., Gendreau
et al., 2001; Taxman, 1999b). Enhanced monitor-
ing of offenders in these programs often leads to a
greater detection of infractions and therefore, para-
doxically, to seemingly worse outcomes. 
In practice, intermediate sanctions typically have
been administered in isolation from treatment, with
an emphasis on monitoring and sanctioning at the
expense of potential rehabilitative functions. When
they have been administered in conjunction with treat-
ment, they have generally produced an average of a
10 percentage-point reduction in recidivism (e.g.,
Gendreau et al., 2001), equivalent to what is com-
monly obtained from prison-based treatment pro-
grams.
PUBLIC HEALTH STRATEGIES
In a pure public health approach to drug-involved
offenders, drug abuse or dependence is viewed as a
disease that requires treatment rather than confine-
ment or punishment. Accordingly, identifying drug
abuse problems among offenders and referring those
individuals to treatment in the community is con-
In dealing with drug abusers who are criminal
justice offenders, many clinicians and service providers
support a public health perspective, contending that
clients are best served through a focus on treatment,
with only minimal involvement of the criminal jus-
tice system. They sometimes find themselves at odds
with public safety proponents who say that criminal
offenders require constant supervision to succeed.
Both views are valid, but neither is adequate in itself.
Research has shown that neither the pure public safety
nor an exclusively public health approach to the prob-
lem works fully; instead, it supports an integrated
approach that has very specific implications for best
practices (see Marlowe, 2002, for review). This arti-
cle briefly reviews results obtained from one-dimen-
sional public safety and public health strategies and
presents promising findings from integrated public
health-public safety programs. Finally, the implica-
tions for best treatment practices and client-program
matching are discussed.
PUBLIC SAFETY STRATEGIES
Drug abuse is illegal and drug abusers are responsible
for a disproportionate amount of crime and violence.
Society often imprisons drug abusers to protect the
public and deter further drug use. Yet, within 3 years
of release from prison, approximately two-thirds of
all offenders, including drug offenders, are rearrested
for a new offense, one-half are convicted of a new
crime, and one-half are reincarcerated for a new crime
or a parole violation (Langan and Levin, 2002). In
some studies, 85 percent of drug-abusing offenders
returned to drug use within 1 year of release from
prison, and 95 percent returned to drug use within 3
years (e.g., Martin et al., 1999). Providing drug abuse
treatment within prison typically reduces criminal
recidivism rates by only about 10 percentage points
(e.g., Gendreau et al., 2001; Pearson and Lipton,
1999). Moreover, in the absence of followup treat-
ment in the community, drug use outcomes are often
indistinguishable between offenders who attended in-
prison drug abuse treatment and those who received
no treatment in prison (e.g., Marlowe, 2002; Martin
et al., 1999). 
Drug abuse treatment in prison does, however,
confer limited, short-term benefits. Studies indicate
that in-prison treatment is associated with fewer dis-
ciplinary infractions by inmates and reduced absen-
teeism by correctional staff (Prendergast et al., 2001).
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sidered to be potentially the most effective way to turn
them away from drug abuse and repeated crime. Case
management to facilitate referral and coordinate ancil-
lary services for the offender-patients also is believed
to influence the success of a public health strategy.
Referral to Treatment
To benefit from treatment, clients must attend the ses-
sions and participate in the interventions. Evidence
from the Drug Abuse Treatment Outcome Study, which
included an evaluation of a nationally representative
sample of outpatient and long-term residential drug
treatment programs, suggests that 3 months of par-
ticipation in drug treatment may be a minimum thresh-
old for detecting dose-response effects for the inter-
ventions (Simpson et al., 1997). That is, with less than
3 months of treatment, there may not be a significant
correlation between time in treatment and outcomes.
It also appears that 6 to 12 months of treatment may
be a further threshold for observing lasting reductions
in drug use. In fact, 12 months of drug abuse treat-
ment may be a median point on the dose-response
curve. Approximately 50 percent of clients who com-
plete 12 months or more of drug abuse treatment
remain abstinent for an additional year after com-
pleting treatment (McLellan et al., 2000).
Unfortunately, attrition in substance abuse treat-
ment programs is unacceptably high. Approximately
70 percent of probationers and parolees drop out of
drug treatment or attend irregularly prior to a 3-month
threshold, and 90 percent drop out prior to 12 months
(e.g., Marlowe, 2002; Taxman, 1999a; Young et al.,
1991). Comparable attrition rates are found for drug
abuse patients in general (e.g., Stark, 1992). These fig-
ures suggest that, on average, only about 10 to 30 per-
cent of clients, in or out of the criminal justice sys-
tem, receive a minimally adequate dosage of drug
treatment. Perhaps as few as 5 to 15 percent achieve
extended abstinence. 
Of course, these figures are national averages for
treatment-as-usual in community-based settings, and
it is possible that particular regimens may be more
successful at retaining offenders in treatment. Further
research is needed to determine whether some treat-
ment interventions may be more acceptable to offender
populations or superior for retaining offenders in treat-
ment in noninstitutional correctional settings.
Case Management
The use of specially trained case managers to con-
tinuously monitor offenders’ attendance in counsel-
ing, take random urine samples to confirm drug absti-
nence, and provide progress reports to responsible
criminal justice authorities is a strategy that seeks to
ensure that offenders receive adequate dosages of treat-
ment. Yet, adding case-management services to drug
abuse treatment for offenders has produced mixed
findings.
In the 1970s, under the rubric of Treatment
Alternatives to Street Crime (TASC)–later renamed
Treatment Accountability for Safer Communities–hun-
dreds of case-management agencies were founded
across the country to identify and refer drug-using
offenders to a range of treatment services, monitor
their progress in treatment, and report compliance
information to appropriate criminal justice authori-
ties. Federal seed funding for TASC was withdrawn
in the early 1980s, and now these programs generally
rely on a patchwork of local and Federal funds for their
continued existence.
TASC agencies operate very differently across
jurisdictions, with some programs providing treat-
ment services directly, others developing contrac-
tual or formal referral arrangements with treatment
programs, and still others making referrals with few
formal agency linkages. Generally, there are no sys-
tematic sanctions in TASC programs for individuals
who do not comply with their treatment regimens.
Early evaluations of TASC programs concluded
they were generally effective at identifying sub-
stance abuse problems among offenders and making
appropriate treatment referrals. Moreover, in a national
study, TASC clients were more likely to complete a 3-
month threshold of outpatient or residential treat-
ment (48 percent and 57 percent, respectively) than
were clients with no current legal involvement 
(30 percent and 41 percent, respectively) (Hubbard
et al., 1988).
A recent evaluation of five large and representa-
tive TASC programs concluded, however, that effects
on drug use and criminal recidivism were mixed (Anglin
et al., 1999). Drug use was significantly lower for
TASC clients in three of the five sites, and criminal
activity was lower in only two of the sites. These data
suggest that the effects of TASC programs vary con-
siderably, depending upon how well the programs
carry out their case-management responsibilities. It
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is reasonable to hypothesize that TASC agencies will
be most effective if they have moderate caseloads,
meaningful control over the quality of the services
their clients receive, and the ability to provide mean-
ingful consequences if clients fail to attend treatment
or continue to use drugs. 
INTEGRATED PUBLIC HEALTH-PUBLIC
SAFETY STRATEGIES
Integrated public health-public safety strategies blend
the functions of the criminal justice system and the
drug abuse treatment system in an effort to optimize
outcomes for offenders (Marlowe, 2002). Substance
abuse treatment assumes a central role in these pro-
grams, rather than being peripheral to punitive ends,
and is provided in clients’ community-of-origin,
enabling clients to maintain family and social contacts
and seek or continue in gainful education or employ-
ment. Responsibility for ensuring clients’ attendance
in treatment and avoidance of drug use and criminal
activity is not, however, delegated to treatment per-
sonnel, who may be unprepared or disinclined to deal
with such matters and who have limited power to
coerce patients to attend. The criminal justice system
maintains substantial supervisory control over offend-
ers and has enhanced authority through plea agree-
ments and similar arrangements to respond rapidly
and consistently to infractions in the program. 
Noteworthy examples of recent integrated pub-
lic health-public safety strategies include drug courts
and work-release therapeutic communities, which are
described in the following sections. While these cer-
tainly are not the only conceivable models of inte-
grated strategies, they are the only ones that studies
have consistently found effective in reducing drug use
and recidivism.
Programs that represent the public health-pub-
lic safety integration strategy and that have demon-
strated effectiveness share a core set of attributes:
•They provide treatment in the community.
•They offer the opportunity for clients to avoid incar-
ceration or a criminal record.
• Clients are closely supervised to ensure compliance.
•The consequences for noncompliance are certain and
immediate.
Drug Courts
Drug courts constitute a clear paradigm of an inte-
grated public health-public safety strategy that has
shown promise for reducing drug use and recidivism
among probationers and pretrial defendants. Drug
courts are separate criminal court dockets that pro-
vide judicially supervised treatment and case-
management services for drug offenders in lieu of pros-
ecution or incarceration. The core components of a
drug court typically include regular status hearings in
court, random weekly urinalyses, mandatory com-
pletion of a prescribed regimen of substance abuse
treatment, progressive negative sanctions for program
infractions, and rewards for program accomplish-
ments. 
Common examples of negative sanctions include
verbal reprimands by the judge, writing assignments,
and brief intervals of detention. Common examples
of rewards include verbal praise, token gifts, and grad-
uation certificates. Counseling requirements may also
appropriately be decreased when the client complies
well with treatment or increased if he or she has poor
attendance or participation or other problems. Clients
who satisfactorily complete the program may have
their current criminal charges dropped or may be sen-
tenced to time served in the drug court program.
Defendants are generally required to plead guilty or
“no contest” as a precondition of entry into drug court.
Therefore, termination from the program for non-
compliance ordinarily results in a criminal drug con-
viction and sentencing to supervised probation or
incarceration.
The evidence is clear that drug courts can increase
clients’ exposure to treatment. Reviews of nearly 100
drug-court evaluations concluded that an average of
60 percent of drug court clients completed a year or
more of treatment, and roughly 50 percent graduated
from the program (Belenko, 1998, 1999, 2001). This
compares favorably to typical retention rates in com-
munity-based drug treatment programs where, as
noted, more than 70 percent of clients on probation
and parole drop out of drug treatment or attend irreg-
ularly within 3 months, and 90 percent drop out in
less than 1 year. 
Promising, although less definitive, is the evi-
dence with regard to the effects of drug courts on drug
use and crime. Two experimental studies have com-
pared outcomes between participants randomly assigned
to either drug court or a comparable probationary
condition. In one study, the Maricopa County (Arizona)
Drug Court was found to have had no impact on re-
arrest rates 12 months after admission to drug court
In a national
study, TASC
clients were
more likely to
complete a 
3-month
threshold of
outpatient or
residential
treatment than
were clients
with no current
legal involve-
ment.than did individuals on standard probation or inten-
sive probation (Belenko, 1998, 1999, 2001). The mag-
nitudes of the posttreatment effects are comparable
to the 15 percentage-point reduction in recidivism
obtained in the two experimental studies reviewed
above. 
It is important to note, however, that many drug
court evaluations have used systematically biased com-
parison samples, such as offenders who refused, were
deemed ineligible for, or dropped out of the inter-
ventions. This may have led to an overestimation of
positive outcomes for drug court clients in some stud-
ies because the comparison subjects are likely to have
had more severe criminal histories or lower motiva-
tion for drug abuse treatment from the outset. Further,
most of the studies evaluated outcomes only during
the course of drug court or up to 1 year postdischarge,
and hardly any studies have assessed substance-use
outcomes after discharge. Thus, we know little about
how drug court clients generally fare after the crimi-
nal justice supervision ends.
These limitations in the extant research on drug
courts led the congressional General Accounting Office
(GAO) to conclude there are insufficient data avail-
able to gauge the effectiveness of federally funded drug
court programs in this country (GAO, 2002). In
response to the GAO report, the National Institute of
Justice (NIJ) released a request for proposals for long-
term client-impact evaluations of up to 10 drug courts
that will include assessments of postprogram recidi-
vism, drug use, employment, and psychosocial func-
tioning and will include suitable comparison condi-
tions. These evaluations are expected to shed further
light on the long-term impact of drug courts.
Work-Release Therapeutic Communities
Encouraging results have been reported for therapeu-
tic community (TC) programs targeted to individu-
als paroled from prison or conditionally transferred
to a correctional work-release facility in the commu-
nity. TCs are residential treatment programs that iso-
late clients from drugs, drug paraphernalia, and affili-
ations with drug-using associates. The peers in TCs
influence each other by confronting negative person-
ality traits, punishing inappropriate behaviors, reward-
ing positive behaviors, and providing mentorship and
camaraderie. Clinical interventions commonly include
confrontational encounter groups, process groups, com-
munity meetings, and altruistic volunteer activities. 
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(Deschenes et al., 1995). However, a significant
“delayed effect” was detected at 36 months, at which
time 33 percent of the drug court participants had
been rearrested, compared to 47 percent of subjects
in various probationary tracks (Turner et al., 1999). 
Similarly, in a randomized study of the Baltimore
City Drug Treatment Court, 48 percent of drug court
clients and 64 percent of adjudication-as-usual
control subjects were rearrested within 1 year of admis-
sion (Gottfredson and Exum, 2002). At 2 years post-
admission, 66 percent of the Baltimore drug court
participants and 81 percent of the controls had been
rearrested for some offense, and 41 percent of the
drug court participants and 54 percent of the con-
trols had been rearrested for a drug-related offense
(Gottfredson et al., 2003).
Nearly 100 quasi-experimental evaluations have
compared outcomes between drug court participants
and nonrandomized comparison groups. In the major-
ity of these evaluations, drug court clients achieved
significantly greater reductions—differences of approx-
imately 20 to 30 percentage points during treatment
and 10 to 20 percentage points after treatment—in
drug use, criminal recidivism, and unemployment
Elements of Successful Programs
E
ffective programs such as drug courts and work-release therapeutic
communities have the following elements in common:
•  Treatment in the community. For treatment gains to generalize and be sus-
tained, clients require opportunities to practice new skills in the community
environment. In contrast, incarceration removes individuals from family and
social supports, interferes with employment or education, and exposes them
to antisocial peer influences. 
•  Opportunity to avoid a criminal record or incarceration. Treatment com-
pletion and drug abstinence are reinforced by removal of criminal justice
sanctions, and clients can avoid the debilitating stigma of a criminal record.
•  Close supervision. The programs include random weekly urinalyses, status
hearings with criminal justice authorities, and monitoring of official rearrest
records. Clinicians provide regular progress reports to supervising authori-
ties and may provide testimony at status hearings. As a result, clients are
less apt to drop out of the system through inattention and cannot exploit
gaps in communication.
•  Certain and immediate consequences. Clients agree to specified sanctions
and rewards that can be readily applied without having to hold new formal
hearings with the full range of due process protections. Termination for non-
compliance or new infractions automatically results in a criminal conviction
and criminal disposition.
To be maximally
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peutic commu-
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Three-year longitudinal evaluations of geo-
graphically diverse correctional TC programs (Knight
et al., 1999; Martin, et al., 1999; Wexler et al., 1999)
suggest that, to be maximally effective, TC services
should be provided along the full continuum of re-
entry, ranging from in-prison treatment, through work-
release treatment, to continuing outpatient treatment.
In all studies, in-prison TC treatment without after-
care had no appreciable effect on drug use or rates of
return to custody. However, offenders who completed
a work-release TC exhibited significant reductions—
of approximately 10 to 20 percentage points—in re-
arrests, returns to custody, and drug use. Moreover,
completion of both in-prison and work-release pro-
grams was associated with a reduction of 30 to 50 per-
centage points in new arrests or returns to custody. 
As with drug courts, these TC studies made inher-
ently biased comparisons, such as contrasting TC
dropouts with graduates, and comparing offenders
who voluntarily entered aftercare to those who did
not. As a result, it is difficult to be confident of the
actual magnitude of the effects. Nevertheless, the results
underscore the importance of providing aftercare serv-
ices to offenders once they are released from prison.
It is not sufficient to provide inmates with referral
to a community treatment program. It is essential to
prepare them for what to expect, to facilitate the refer-
ral by transferring the relevant paperwork and clini-
cal information to the referral source, and to follow
up to ensure that the individual has completed the
referral (Cornish and Marlowe, in press). Moreover,
as noted earlier, providing in-prison TC treatment
may increase the probability that an inmate will con-
tinue in aftercare services. It would seem optimal to
begin the continuum of drug treatment, including ini-
tial assessments and motivational enhancement inter-
ventions, prior to the inmate’s release.
Unfortunately, TCs are the only community-
reentry programs that have been systematically stud-
ied. There are virtually no outcome data available
on other types of postprison initiatives. Recently,
NIDA released a request for applications to develop
the Criminal Justice-Drug Abuse Treatment Services
Research System, which is intended to, among other
things, provide support for controlled studies of var-
ious community-reentry strategies for drug-involved
offenders.
BEST PRACTICES
Proponents of a pure public health perspective com-
monly argue that the involvement of criminal justice
authorities in treatment can be disruptive and poten-
tially harmful for a number of reasons:
• Clients may mistrust treatment providers who are
allied with law enforcement and may not confide
important clinical information for fear it will be
used against them.
• Treating sick people like criminals may breed coun-
tertherapeutic feelings of resentment, hostility, or
hopelessness.
• Forcing clients to spend time in criminal justice set-
tings may have the unintended consequence of social-
izing them into a milieu of antisocial behavior.
• Criminal justice supervision is expensive and time-
consuming. Judges, bailiffs, and probation and parole
officers cost money that may then not be available
for formal drug abuse treatment.
Proponents of a pure public safety perspective con-
tend instead that:
• Drug-involved offenders are characteristically impul-
sive and irresponsible.
• These offenders frequently fail to meet their obli-
gations and often do not stay out of trouble unless
they are closely monitored and face immediate, con-
sistent, and severe consequences for their noncom-
pliance.
• Such close monitoring may itself be therapeutic
because it instills a sense of accountability and pro-
vides highly effective behavioral contingencies.
Neither the pure public health position nor the
pure public safety position is often borne out by research.
The available evidence suggests that both may be cor-
rect, but with reference to different clients. Some clients
perform better if they are left alone to develop an effec-
tive therapeutic alliance with their counselor and to
focus on their problems and recovery in treatment.
Others require consistent and intensive supervision
by criminal justice authorities in order to succeed.
The Risk Principle: 
A Foundation for Best Practices
Outcome studies indicate that intensive interventions
are best suited to high-risk offenders who have rela-
tively more severe criminal dispositions and drug-use
histories, but may be ineffective or contraindicated
for low-risk offenders (e.g., Gendreau et al., 2001).
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nal justice literature and is attributed to the idea that
low-risk offenders are less likely to be on a fixed anti-
social trajectory and are more likely to adjust course
readily after a run-in with the law. Therefore, inten-
sive treatment and monitoring may offer little incre-
mental benefit for these individuals, while the cost
is substantial. High-risk offenders, on the other hand,
are more likely to require intensive structure and mon-
itoring to alter their entrenched negative behavioral
patterns.
The greatest risk factors reported in the litera-
ture for failure in offender rehabilitation programs are
a younger age during treatment (typically under age
25), an earlier age of involvement in crime (especially
violent crime prior to age 16), an earlier age of begin-
ning drug use (typically prior to age 14), a comorbid
diagnosis of antisocial personality disorder (APD) or
psychopathy, previous failed efforts in drug treatment
or a criminal diversion program, and first-degree
relatives with drug abuse problems or criminal his-
tories (e.g., Gendreau, 1996). These risk factors are
labeled “static” because they are historical in nature
and are generally unaffected by clinical interventions.
“Dynamic” risk factors, which can be targeted for
change during treatment, include such things as anti-
social attitudes, criminal associations, and gang mem-
bership. 
The research program at the Treatment Research
Institute (TRI) at the University of Pennsylvania has
validated the Risk Principle among drug court clients.
With funding from NIDA and the Center for Substance
Abuse Treatment (CSAT), TRI randomly assigned
misdemeanor drug court clients either to an intensive
level of judicial supervision involving biweekly status
hearings in court, or to a low level of supervision in
which they were monitored by treatment personnel
and had status hearings (see “A Basis for Matching
Patients to Supervision Regimens”) only as needed in
response to sustained noncompliance or serious infrac-
tions. The results revealed no differences for partici-
pants as a whole in counseling attendance, urinalysis
results, graduation rates, or self-reported substance
use or criminal activity during treatment or at 6 months
or 12 months postadmission (Marlowe et al., 2002;
Marlowe et al., 2003a). 
Importantly, however, the study showed a sig-
nificant interaction effect, depending on participants’
risk status. Participants who met DSM-IV diagnostic
criteria for APD or had prior experiences in drug abuse
treatment attained significantly greater drug absti-
nence and were significantly more likely to succeed in
graduating from the drug court program when they
were assigned to biweekly hearings. Conversely, clients
without APD or a prior history in drug treatment per-
formed better when they were assigned to as-needed
hearings (Festinger et al., 2002). These same findings
were replicated in two additional jurisdictions, in rural
and urban communities and serving both misdemeanor
and felony offenders (Marlowe et al., 2003b; Marlowe
et al., in press).
In the replication studies, the magnitudes of the
interaction effects were quite large. For instance, mis-
During a 14-week misdemeanor drug court program, clients with 
antisocial personality disorder (APD) who were assigned to biweekly
judicial status hearings turned in significantly more drug-free urine
samples than similarly diagnosed offenders without a fixed schedule
for hearings. Drug court clients without an APD diagnosis, con-
versely, did better when assigned to as-needed hearings.
Source: Festinger et al., Drug and Alcohol Dependence, 2002. Copyright 2002 by
D.S. Festinger, D.B. Marlowe, P.A. Lee, K.C. Kirby, G. Bovasso, A.T. McLellan, and
Elsevier Press. Used with permission. 
0
1
2
3
4
5
6
7
Non-APD APD
Biweekly Hearings As-Needed Hearings
*p < .05  (n=30) (n=69) (n=30) (n=52)


Drug-F
ree Urine Samples
A Basis for Matching Patients to 
Supervision RegimensRESEARCH REVIEWS—CRIMINAL JUSTICE • 11
demeanor participants with a prior drug treatment
history provided substantially more drug-free urine
specimens during the first 3 months of drug court
(11.50 versus 2.67) and were substantially more likely
to graduate successfully from the program (83 per-
cent versus 17 percent) when they were assigned to
biweekly status hearings as opposed to as-needed hear-
ings. Similarly, felony participants with APD reported
engaging in substantially fewer days of alcohol intox-
ication when they were assigned to biweekly status
hearings as opposed to as-needed hearings (0.50 ver-
sus 4.83).
The large magnitude of these effects made it eth-
ically necessary to stop the studies and to institute
remedial procedures for the high-risk participants
assigned to the as-needed condition. The resulting
small cell sizes (n=6 per cell in some analyses) do raise
concerns about whether the study samples were ade-
quately representative of drug court clients generally.
Because the findings were reproduced in sequential
experimental studies and are supported by a previ-
ously validated criminal justice theory (i.e., the
Risk Principle), we have considerable confidence in
their reliability. Nevertheless, it is essential to repli-
cate this work in new settings with a larger number
of participants.  
It is also important that the interaction effects,
although hypothesized in advance, were not under
direct experimental control. TRI is currently con-
ducting a prospective matching study in which drug
court clients are randomly assigned to different sched-
ules of judicial status hearings on the basis of an assess-
ment of whether they have APD or a prior drug treat-
ment history. The results of this work will permit
an estimate of the effect size and relative costs and
benefits of assigning drug offenders to different serv-
ice tracks in drug court based upon their risk level.
Our finding that APD and drug treatment
history were the most robust indicators of risk level
among the drug court clients in our studies is quite
consistent with prior research on the greatest risk fac-
tors for criminal reoffending (e.g., Gendreau, 1996).
It is, however, possible that other risk factors will
emerge in future matching studies and permit a more
sensitive classification of high-risk and low-risk offend-
ers. Further research is also needed to interpret the
influence of prior drug treatment history. It is an open
question whether this variable reflects the severity of
participants’ drug problems, past negative experiences
with standard drug treatment, or some other, unknown
influence. Further inquiry is needed to gain a defin-
itive grasp of the nature of this interaction effect.
From Risk to Regimen
In the three jurisdictions TRI studied, approximately
50 percent of the felony and misdemeanor drug court
clients met criteria for being at high risk, meaning
they had APD, a prior drug treatment history, or both.
These findings suggest that no more than half of drug
offenders might reasonably be expected to perform
adequately in the type of low-intensity, nonjudicially
managed diversionary intervention exemplified in
recent State policy initiatives such as Proposition 36
or Proposition 200 (see “States Move to Low-Intensity
Intervention for Nonviolent Drug Offenders”). A sub-
stantial proportion of drug offenders could be at risk
for failing in such an intervention, suggesting that
criminal diversion statutes should incorporate some
mechanism to permit poorly responding individu-
als to be readily transferred to a judicially managed
program. 
The findings have further implications for best
treatment practices and for ethical guidelines for drug
treatment providers (see “Confidentiality Guidelines
for Integrated Approaches”). 
Ideally, there might be (at least) two tracks in
treatment programs, involving different service arrange-
ments with courts and probation and parole offices.
Low-risk clients could be treated with the general
client population. High-risk clients, however, might
be treated separately in a track that provides routine
progress reports to criminal justice authorities and
has full-time court liaisons who can accompany clients
to status hearings in court or to probation or parole
offices. In practice, such court liaisons typically are
professional case managers who may be employed
either by the substance abuse treatment system or by
the criminal justice system through law enforcement
or substance abuse block grants or through specific
drug court implementation grants. 
Integrated approaches should incorporate the
ability to readily transfer clients between tracks accord-
ing to their actual conduct in treatment. Demonstrated
success in the program could be rewarded with reduc-
tion of monitoring requirements, whereas evidence
of poor performance could be met with an increase
of treatment services or of supervisory obligations
such as more frequent urinalyses or court hearings.
Intensive treat-
ment and mon-
itoring may
offer little
incremental
benefit for low-
risk offenders.12 • SCIENCE & PRACTICE PERSPECTIVES—AUGUST 2003
In truly integrated programs, the criminal justice sys-
tem retains ultimate jurisdiction or authority over
clients; therefore, it is possible to increase the inten-
sity of services readily in response to infractions with-
out having to hold new court hearings with formal
due-process requirements such as the right to notice,
to counsel, and to present evidence. 
The content of treatment might also be tailored
to clients’ risk levels. Highly structured behavioral or
cognitive-behavioral interventions are ideally suited
for many offenders, particularly those identified as
“high risk” (e.g., Cornish and Marlowe, in press;
Gendreau et al., 2001). In contrast, insight-ori-
ented or group-process interventions have been asso-
ciated with increased rates of drug use and recidivism
among high-risk offenders, and educational or drug-
awareness sessions have been shown to have no effect
for any offenders (e.g., Pearson and Lipton, 1999;
Taxman, 1999b). The worst outcomes have been seen
with insight-oriented treatments that presume a well-
spring of anxiety, depression, or low self-esteem under-
lies antisocial conduct. The best results have been
obtained from programs that focused on restructur-
ing clients’ distorted antisocial cognitions, correcting
their erroneous assumptions about the motives of oth-
ers, and teaching adaptive problemsolving, com-
munication, and coping skills. Of course, observable
and diagnosable symptoms of depression or anxiety
should also be targeted in conjunction with any treat-
ment regimen.
Furthermore, in the most successful programs,
staff members have been in a position to reliably detect
clients’ accomplishments and infractions in the pro-
gram and to apply rewards for desired behaviors and
negative sanctions for undesired behaviors (e.g., Harrell
and Roman, 2001; Marlowe and Kirby, 1999; Taxman,
1999b). For instance, the most effective programs
regularly monitor clients’ substance use through ran-
dom breathalyzer tests and urinalyses. Drug-free test
results are met with rewards, such as reduced moni-
toring requirements, reduced criminal sanctions, or
goods and services that support a productive lifestyle.
Drug-positive results, on the other hand, are met with
such sanctions as loss of privileges, increased coun-
seling requirements, or a brief return to detention. If
a particular program’s philosophy or structure can-
not easily accommodate such an approach, that pro-
gram might consider having a separate, intensive,
States Move to Low-Intensity Intervention for Nonviolent Drug Offenders
A
few States have passed referenda aimed at diverting drug-possession offenders into community-based treatment in lieu of judicial supervi-
sion. California’s Proposition 36 and Arizona’s Proposition 200 were each passed by approximately two-thirds of voters. These statutes
require, among other things, that nonviolent offenders convicted of drug possession, drug use, or transportation for use be sentenced to proba-
tion with drug abuse treatment as a mandatory condition. Upon successful completion of treatment and substantial compliance with probation,
the offender is entitled to have his or her arrest record and conviction record expunged. This would entitle the individual to truthfully respond on
an employment application or similar document that he or she has not been arrested for a drug-related offense.    
Many jurisdictions offer this form of diversion—sometimes called “Deferred Judgment” or “Probation Without Verdict”—to first- or second-
time offenders charged with relatively minor crimes such as disturbing the peace, public intoxication, petty theft, or driving while intoxicated.
However, Proposition 36 and Proposition 200 extend the opportunity, as a matter of right, to all nonviolent drug-possession offenders who are
not currently charged with another felony or serious misdemeanor offense and who have not been convicted of or incarcerated for such an
offense within the preceding 5 years. Moreover, Proposition 36 and Proposition 200 generally provide offenders with three chances to succeed in
the program. If an offender violates a drug-related condition of probation or is charged with a new drug-possession offense, the statutes simply
provide for a second and then a third opportunity at diversion unless, according to the statute, the State can make the difficult showing that the
offender is a “danger to others” or is “unamenable to drug treatment.”
A ballot initiative comparable to Propositions 36 and 200 was passed in the District of Columbia, and the Hawaii State Legislature enacted a
similar law in 2002. Equivalent referenda were withdrawn from the 2002 elections in Florida and Michigan on technical, procedural grounds and
are likely to be placed on the ballot again for the next elections. Kansas and several other State legislatures also are considering bills containing
similar statutory provisions. Yet, despite their widespread and rapidly growing appeal, no reliable data are available on the efficacy of these types
of diversionary programs in general or on specific initiatives such as Proposition 36 and Proposition 200.
Studies of Proposition 36 are currently under way in California. Various counties have been implementing Proposition 36 differently at the pro-
grammatic level. For instance, some counties are administering Proposition 36 through the existing drug court system using ongoing court hear-
ings. Comparisons of client outcomes across different service models may reveal the best way to implement these types of initiatives.RESEARCH REVIEWS—CRIMINAL JUSTICE • 13
behavioral or cognitive-behavioral track for high-risk
offenders or might consider not accepting referrals to
treat such offenders. 
Pharmacological interventions are seriously
underutilized in the criminal justice system despite
the fact that several medications have demonstrated
success for reducing substance use and crime among
offenders (e.g., Cornish and Marlowe, in press).
Methadone maintenance treatment, in particular, has
been consistently demonstrated in numerous exper-
imental studies to reduce drug use and criminal activ-
ity among opiate addicts, with effects many times the
size of hospital-based detoxification, drug-free out-
patient treatment, and residential treatment (e.g.,
Platt et al., 1998). In a controlled experimental study,
researchers at the University of Pennsylvania similarly
found that Federal probationers who were random-
ized to receive naltrexone in combination with psy-
chosocial counseling had lower rates of opioid-
positive urines and were less likely to be reincarcer-
ated for probation violations than those receiving psy-
chosocial counseling alone without naltrexone (Cornish
et al., 1997). Subsequent studies by the same inves-
tigators are examining the effects of oral and depot
naltrexone among State parolees, probationers, and
drug court clients. Preliminary data from those stud-
ies suggest that oral naltrexone may be more effective
in retaining parolees in treatment than standard psy-
chosocial treatment alone.
It is possible that opioid-antagonist medications
such as naltrexone may be more palatable to policy-
makers and criminal justice practitioners because they
are not perceived as substituting one addictive sub-
stance for another, as is commonly ascribed to
methadone. Further research is needed to evaluate the
acceptability and effects of these types of medications
in correctional settings, and to identify and resolve
barriers to the use of efficacious medications with
criminal justice clients.
CONCLUSION
Research evidence suggests that public health propo-
nents and public safety proponents may have differ-
ent types of drug-involved offenders in mind. Certain
offenders might be well suited to being diverted into
treatment and given an opportunity to avoid the stigma
of a criminal record. Others require intensive moni-
toring and consistent consequences for noncompli-
ance in treatment. Just as clinical interventions should
be targeted to the specific needs of each individual,
the degree to which criminal justice authorities and
drug treatment providers actively coordinate their
functions for a particular client should be based upon
a careful assessment of that client’s risk status and
ongoing monitoring of his or her progress in treat-
ment. Programs that jointly allocate responsibility
for clients to criminal justice and drug abuse treat-
ment professionals are in the best position to respond
readily by increasing or decreasing their coordination
of efforts, depending upon clients’ performance in
the program. This provides maximum flexibility and
access to resources for handling an impaired and poten-
tially resistant population.
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tured behav-
ioral or 
cognitive-
behavioral
interventions
are ideally
suited for many
offenders, par-
ticularly those
identified as
“high risk.”
Confidentiality Guidelines for Integrated Approaches
D
rug treatment providers are typically socialized to maintain strict con-
fidentiality and nonporous professional boundaries between them-
selves and criminal justice authorities. The author’s drug court studies sug-
gest this might, indeed, be therapeutic for low-risk clients who may need a
safe and discreet setting to focus on their problems. Such an approach,
however, would appear to be contraindicated for high-risk clients who could
deliberately evade detection of infractions or might exploit gaps in commu-
nication and monitoring. 
Many clinicians misunderstand their ethical and legal obligations with
regard to confidentiality for criminal justice clients. Federal law and most
State laws expressly permit substance abuse treatment programs to dis-
close information about clients to criminal justice officials who have made
program participation a condition of the disposition of a criminal proceed-
ing, probation, parole, or conditional release from prison or jail (e.g.,
Marlowe, 2001). Disclosure must be limited to those individuals who need
the information to meet their duty to monitor the client’s progress. Notably,
Federal law prohibits the use of such information to investigate or prose-
cute any new charge against the client. The information can be used only to
monitor the client’s progress during the immediate treatment episode.
The Health Insurance Portability and Accountability Act (HIPAA) does
not add substantive restrictions on the sharing of health-related informa-
tion in this context. Rather, HIPAA requires treatment providers to clearly
inform clients about how their personal health information will be used and
to give them an opportunity to object to such uses. Clinicians may share
treatment information with criminal justice professionals so long as they
provide clients with appropriate notice of their agency’s privacy practices
and the limitations on confidentiality, and they obtain specific authoriza-
tions from the client to disclose the information in that manner.14 • SCIENCE & PRACTICE PERSPECTIVES—AUGUST 2003
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